Testing two nerve pain medicines for teens with chronic nerve pain
Treatments studied
Part of Brain & nervous system, Pain clinical trials.
This study tests whether gabapentin or oxcarbazepine can reduce chronic nerve-related pain in children and teens. It may help by improving pain and comfort when standard approaches haven’t worked well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 8 and 18 years old
- Your nerve pain has lasted at least 4 weeks
- Your pain feels like nerve symptoms such as burning, tingling, or pain from light touch
- Your current pain is moderate to severe (about 4 to 10 on a 0–10 scale)
- Your condition fits one of these: complex regional pain, fibromyalgia, nerve-root/back nerve pain, spinal cord injury pain, erythromelalgia, small-fiber nerve problems, or certain nerve/plexus injuries
- A parent can give consent (and help with an interpreter if needed)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a device that uses mild electrical pulses to reduce nerve pain in children with cancer. It may offer a drug-free way to manage pain.
This study tests whether gabapentin can reduce how much opioid pain medicine children need after certain major chest or heart surgeries. If it works, it may lower opioid-related side effects while still helping with postoperative pain.
This study looks at nerve pain in children and teens who had an amputation before a certain age. It aims to understand how common and how severe this pain is after amputation, and uses simple questionnaires to find out.
This trial tests how well two types of peripheral nerve stimulation (PNS) devices relieve chronic pain caused by a single nerve injury. It looks for people who already have a referral for PNS therapy as part of their usual care and who have gotten at least 50% relief from a diagnostic nerve block.
This Phase 2 study tests cannabis-derived products to see if they reduce neuropathic (nerve-related) pain in veterans. It may help people whose pain is persistent and causes significant daily impact, especially if certain exam tests show allodynia (pain from normally non-painful touch).
This study follows kids who have a specific type of chronic pain (headaches, stomach pain, or muscle/joint pain) to better understand how pain changes over time. It also checks whether certain factors are linked to those pain patterns.
Hear when a new Pediatric Chronic Neuropathic Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.